ask="6.73"
ask_size="200"
average_daily_volume="972787"
bid="6.36"
bid_size="500"
book_value="0.05"
change="+0.00"
change_from_200_day_moving_average="1.60"
change_from_50_day_moving_average="0.22"
change_from_52_week_high="-1.11"
change_From_52_week_low="4.82"
change_in_percent="+0.00%"
close="6.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="6.54"
high_52_weeks="7.56"
last_trade_date="1/27/2017"
last_trade_price="6.45"
last_trade_size="22061"
last_trade_time="4:00pm"
low="6.36"
low_52_weeks="1.63"
market_capitalization="475.74M"
moving_average_200_day="4.85"
moving_average_50_day="6.23"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.49"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+32.98%"
percent_change_from_50_day_moving_average="+3.51%"
percent_change_from_52_week_high="-14.68%"
percent_change_from_52_week_low="+295.71%"
previous_close="6.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="119.44"
price_per_sales="21.65"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.02"
stock_exchange="NMS"
symbol="BCRX"
volume="608302"
weeks_range_52="1.63 - 7.56"
